Biomodal

Biomodal (formerly Cambridge Epigenetix) is a Cambridge, UK genomics and epigenetics company whose duet multiomics solutions capture genetic and epigenetic information from a single low-input DNA sample in one experiment, giving researchers access to the six-base genome (the four canonical bases plus 5-methylcytosine and 5-hydroxymethylcytosine). Its products include the duet multiomics solution evoC and duet +modC library-prep assays, the biomodal CLI and duet post-sequencing pipeline (alignment, methylation quantification, and variant calling), and the modality XPLR analysis software. The technology is applied to cancer and liquid-biopsy research, neurodegenerative disease, aging, precision medicine, and non-invasive prenatal testing. Biomodal is a portfolio company of GV (Google Ventures) and was added to the API Evangelist network as a life-sciences provider profile.

Biomodal is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Genomics, Epigenetics, and Multiomics.

Biomodal’s developer surface includes documentation, engineering blog, support, CLI, and 6 more developer resources.

🌐 Visit website 📡 Source on GitHub

21.3/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyLife SciencesGenomicsEpigeneticsMultiomicsDNA SequencingBioinformaticsPrecision Medicine

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 21.3/100 · emerging

Contract Quality 0.0 / 25

Developer Ergonomics 6.1 / 20

Commercial Clarity 6.8 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/biomodal: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Get Started 2

Portal, sign-up, and the first successful call

DeveloperPortal

DeveloperPortal

Login

Documentation 1

Reference material describing how the API behaves

Documentation

Documentation

Build 1

SDKs, sample code, and the tooling you integrate with

CLI

CLI

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: biomodal
name: Biomodal
description: Biomodal (formerly Cambridge Epigenetix) is a Cambridge, UK genomics and epigenetics company whose duet multiomics
  solutions capture genetic and epigenetic information from a single low-input DNA sample in one experiment, giving researchers
  access to the six-base genome (the four canonical bases plus 5-methylcytosine and 5-hydroxymethylcytosine). Its products
  include the duet multiomics solution evoC and duet +modC library-prep assays, the biomodal CLI and duet post-sequencing
  pipeline (alignment, methylation quantification, and variant calling), and the modality XPLR analysis software. The technology
  is applied to cancer and liquid-biopsy research, neurodegenerative disease, aging, precision medicine, and non-invasive
  prenatal testing. Biomodal is a portfolio company of GV (Google Ventures) and was added to the API Evangelist network as
  a life-sciences provider profile.
url: https://raw.githubusercontent.com/api-evangelist/biomodal/refs/heads/main/apis.yml
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://biomodal.com/wp-content/uploads/2023/05/biomodal-social-share.webp
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Life Sciences
- Genomics
- Epigenetics
- Multiomics
- DNA Sequencing
- Bioinformatics
- Precision Medicine
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://biomodal.com
- type: DeveloperPortal
  url: https://software-docs.biomodal.com/en/latest/index.html
- type: Documentation
  url: https://biomodal.com/documentation/
- type: Blog
  url: https://biomodal.com/news/
- type: Support
  url: https://biomodal.com/contact/
- type: Login
  url: https://app.biomodal.com
- type: TermsOfService
  url: https://biomodal.com/terms-of-use/
- type: PrivacyPolicy
  url: https://biomodal.com/privacy-policy/
- type: CLI
  url: cli/biomodal-cli.yml
- type: DomainSecurity
  url: security/biomodal-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence